1. Experimental Therapeutics Group, Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI); Bellinzona Switzerland
2. Prostate Cancer Biology Group, Institute of Oncology Research (IOR), Università della Svizzera Italiana (USI); Bellinzona Switzerland
3. Department of Oncology, Faculty of Biology and Medicine, University of Lausanne; Lausanne Switzerland